ALLR Allarity Therapeutics, Inc. - Common stock
$1.60
价格 · 五月 22, 2026
截至...的财报数据 五月 15, 2026
52周区间
$1–$2
52% of range
分析师评级
BUY
7 analysts
目标价
$10
+509% upside
P/E (TTM)
-0.0
ROE
-102.1%
净利润率
-3509.7%
ALLR 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.60
市值
$17M
P/E (TTM)
-0.0
每股收益 (TTM)
$-10.26
营收 (TTM)
$320.0K
股息收益率
—
ROE
-102.1%
负债/权益
—
52周区间
$1 – $2
ALLR 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$320.0K
2024-12-31
→
2025-12-31
EPS
$-10.26
2021-12-31
→
2023-12-31
自由现金流
$-15M
2022-12-31
→
2025-12-31
利润率
-3509.7%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
ALLR
同行中位数
P/E (TTM)
-0.0
—
P/S (TTM) (市销率 (TTM))
54.3
14.0
P/B (市净率)
1.8
2.0
Price / FCF (股价/自由现金流)
-1.2
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
ALLR
同行中位数
Operating Margin (营业利润率)
-3939.1%
—
Net Profit Margin (净利润率)
-3509.7%
-3396.1%
ROA
-54.9%
-68.9%
ROE
-102.1%
-110.3%
ROIC
-128.3%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
ALLR
同行中位数
Current Ratio (流动比率)
2.1
1.4
Quick Ratio (速动比率)
1.7
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
ALLR
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
ALLR
同行中位数
ALLR 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
7 位分析师
- 强烈买入 2 28.6%
- 买入 4 57.1%
- 持有 1 14.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
1 位分析师 · 2026-05-26
最低
$9.75
最高
$9.75
中位数目标
$9.75
+509.4%
平均目标
$9.75
+509.4%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
1.1%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.17 | $-0.22 | 0.05% |
| 2025年12月31日 | $-0.21 | $-0.22 | 0.01% |
| 2025年9月30日 | $-0.19 | $-0.23 | 0.04% |
| 2025年6月30日 | $-0.15 | $-0.21 | 0.06% |
| 2024年9月30日 | $-7.71 | $-8.69 | 0.98% |
| 2024年6月30日 | $-3.30 | $-8.78 | 5.5% |
同行比较 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ALLR | $17M | -0.0 | — | -3509.7% | -102.1% | — |
| SHPH | $4M | -0.3 | 0.00% | — | -400.1% | — |
| DYAI | — | -4.1 | -11.6% | — | — | — |
| AIXC | $12M | -0.3 | — | — | -110.8% | — |
| CLRB | — | -0.4 | — | — | — | — |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| JSPR | — | -0.5 | — | — | — | — |
| VTGN | — | -1.5 | -54.3% | -10579.8% | -67.9% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 13
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Revenue | $320.0K | $0 | |
| R&D Expense | $7M | $6M | |
| SG&A Expense | $6M | $11M | |
| Operating Expenses | $13M | $27M | |
| Operating Income | $-13M | $-27M | |
| Interest Income | $801.0K | $533.0K | |
| Other Non-op | $1M | $2M | |
| Pretax Income | $-11M | $-25M | |
| Income Tax | $0 | $-381.0K | |
| Net Income | $-11M | $-25M | |
| EPS (Basic) | $-0.78 | $-15.65 | |
| Shares (Basic) | 14,378,942 | 1,606,989 | |
| EBITDA | $-13M | $-27M |
资产负债表 21
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $15M | $20M | |
| Prepaid Expense | $2M | $507.0K | |
| Other Current Assets | $265.0K | $115.0K | |
| Current Assets | $18M | $22M | |
| PP&E (Net) | $330.0K | $309.0K | |
| Intangibles | · | $0 | |
| Total Assets | $18M | $23M | |
| Accounts Payable | $4M | $4M | |
| Accrued Liabilities | $3M | $5M | |
| Short-term Debt | $0 | · | |
| Current Liabilities | $8M | $11M | |
| Deferred Tax | · | $0 | |
| Total Liabilities | $8M | $11M | |
| Common Stock | $3.0K | $1.0K | |
| Paid-in Capital | $144M | $131M | |
| Retained Earnings | $-130M | $-119M | |
| Treasury Stock | $3M | $0 | |
| AOCI | $-1M | $-354.0K | |
| Stockholders' Equity | $10M | $12M | |
| Liabilities + Equity | $18M | $23M | |
| Shares Outstanding | 16,080,980 | 7,302,797 |
现金流 13
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| D&A | · | $9.0K | |
| Stock-based Comp | $482.0K | $71.0K | |
| Deferred Tax | $0 | $-381.0K | |
| Other Non-cash | · | $7M | |
| Operating Cash Flow | $-15M | $-17M | |
| CapEx | $8.0K | $298.0K | |
| Investing Cash Flow | $-8.0K | $-298.0K | |
| Stock Issued | $11M | $37M | |
| Stock Repurchased | $3M | $0 | |
| Net Stock Activity | $8M | $37M | |
| Financing Cash Flow | $11M | $37M | |
| Taxes Paid | · | $0 | |
| Free Cash Flow | $-15M | $-18M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -3939.1% | · | |
| Net Margin | -3509.7% | · | |
| Pretax Margin | -3509.7% | · | |
| EBITDA Margin | -3939.1% | · | |
| ROA | -54.9% | -142.1% | |
| ROE | -102.1% | -197.9% | |
| ROIC | -128.3% | -227.1% |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.1 | 2.1 | |
| Quick Ratio | 1.7 | 1.8 |
效率 1
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $320.0K | $0 | |
| Net Income TTM | $-11M | $-25M | |
| Market Cap | $17M | $9M | |
| P/E | -0.0 | -0.0 | |
| P/S | 54.3 | · | |
| P/B | 1.8 | 0.7 | |
| P / Tangible Book | 1.8 | 0.7 | |
| P / Cash Flow | -1.2 | -0.5 | |
| P / FCF | -1.2 | -0.5 | |
| Earnings Yield | -50908.3% | -46992.3% |
损益表 13
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $25.0K | · | · | · | $0 | |
| R&D Expense | $1M | $2M | $1M | $2M | $1M | |
| SG&A Expense | $1M | $2M | $1M | $2M | $2M | |
| Operating Expenses | $3M | $3M | $3M | $4M | $3M | |
| Operating Income | $-3M | $-3M | $-3M | $-4M | $-3M | |
| Interest Income | $163.0K | $155.0K | $187.0K | $237.0K | $222.0K | |
| Other Non-op | $-62.0K | $-455.0K | $-288.0K | $2M | $304.0K | |
| Pretax Income | · | $-3M | $-3M | $-2M | $-3M | |
| Income Tax | · | $0 | $0 | $0 | $0 | |
| Net Income | $-3M | $-3M | $-3M | $-2M | $-3M | |
| EPS (Basic) | $-0.17 | $-0.19 | $-0.19 | $-0.15 | $-0.25 | |
| Shares (Basic) | 15,968,591 | -27,051,101 | 14,739,800 | 15,543,321 | 11,146,922 | |
| EBITDA | $-3M | · | $-3M | $-4M | $-3M |
资产负债表 20
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $20M | $15M | $17M | $18M | $25M | |
| Prepaid Expense | $4M | $2M | $2M | $1M | $493.0K | |
| Other Current Assets | $108.0K | $265.0K | $113.0K | $116.0K | $110.0K | |
| Current Assets | $35M | $18M | $20M | $21M | $29M | |
| PP&E (Net) | $420.0K | $330.0K | $330.0K | $322.0K | $308.0K | |
| Total Assets | $35M | $18M | $21M | $21M | $30M | |
| Accounts Payable | $4M | $4M | $5M | $5M | $4M | |
| Accrued Liabilities | $2M | $3M | $3M | $3M | $5M | |
| Short-term Debt | $20M | · | · | · | · | |
| Current Liabilities | $28M | $8M | $9M | $9M | $11M | |
| Total Liabilities | $28M | $8M | $9M | $9M | $11M | |
| Total Debt | $20M | · | · | · | · | |
| Common Stock | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $144M | $144M | $144M | $141M | $141M | |
| Retained Earnings | $-133M | $-130M | $-127M | $-124M | $-122M | |
| Treasury Stock | $3M | $3M | $3M | $3M | · | |
| AOCI | $-1M | $-1M | $-2M | $-2M | $-630.0K | |
| Stockholders' Equity | $7M | $10M | $12M | $12M | $19M | |
| Liabilities + Equity | $35M | $18M | $21M | $21M | $30M | |
| Shares Outstanding | 15,818,980 | 16,080,980 | 16,111,461 | 14,619,636 | 17,021,970 |
现金流 11
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| D&A | · | · | · | $12.0K | $11.0K | |
| Stock-based Comp | $160.0K | $47.0K | $132.0K | $164.0K | $139.0K | |
| Other Non-cash | · | · | · | · | $-104.0K | |
| Operating Cash Flow | $-4M | $-3M | $-3M | $-5M | $-3M | |
| CapEx | $64.0K | · | · | · | $0 | |
| Investing Cash Flow | $-64.0K | · | · | · | $0 | |
| Stock Issued | $0 | $0 | $0 | $0 | $11M | |
| Stock Repurchased | $262.0K | $484.0K | $141.0K | $3M | $0 | |
| Net Stock Activity | $-262.0K | · | · | · | $11M | |
| Financing Cash Flow | $20M | $-240.0K | $2M | $-3M | $11M | |
| Free Cash Flow | $-5M | · | · | · | · |
盈利能力 6
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating Margin | -10752.0% | · | · | · | · | |
| Net Margin | -11000.0% | · | · | · | · | |
| EBITDA Margin | -10752.0% | · | · | · | · | |
| ROA | -8.5% | · | -13.6% | -8.9% | -13.1% | |
| ROE | -21.5% | · | -22.5% | -14.5% | -44.8% | |
| ROIC | · | · | -21.0% | -34.0% | -16.3% |
流动性与偿付能力 3
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | · | 2.3 | 2.3 | 2.7 | |
| Quick Ratio | 0.7 | · | 1.9 | 2.0 | 2.3 | |
| Debt / Equity | 2.9 | · | · | · | · |
效率 1
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · |
估值 (TTM) 11
| 指标 | 趋势 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-11M | · | $-19M | $-18M | $-20M | |
| Market Cap | $17M | · | $25M | $15M | $16M | |
| Enterprise Value | $18M | · | · | · | · | |
| P/E | -0.0 | · | -0.0 | -0.0 | -0.0 | |
| P/B | 2.5 | · | 2.1 | 1.2 | 0.9 | |
| P / Tangible Book | 2.5 | · | 2.1 | 1.2 | 0.9 | |
| P / Cash Flow | -3.8 | · | · | · | -5.9 | |
| P / FCF | -3.8 | · | · | · | · | |
| EV / EBITDA | -6.5 | · | · | · | · | |
| EV / FCF | -3.8 | · | · | · | · | |
| Earnings Yield | -50441.3% | · | -34798.1% | -54436.6% | -58677.7% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $320.0K | $0 | — | — | — |
| 营业利润率 % | -3939.1% | — | — | — | 1971.5% |
| 净收入 | $-11M | $-25M | $-12M | $-16M | $-27M |
| 稀释后每股收益 (EPS) | — | — | $-10.26 | $-3093.42 | $-4.19 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 2.1 | 2.1 | — | 0.4 | 1.0 |
| 速动比率 | 1.7 | 1.8 | — | 0.2 | 0.9 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-15M | $-18M | — | $-17M | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。